Serum Fibroblast Growth Factor 21 in human obesity: regulation by hyperinsulinaemia and relationship with energy expenditure and glucose and lipid oxidation

被引：0
|
作者：
Straczkowski, M. [1 ]
Kowalska, I. [1 ]
Nikolajuk, A. [1 ]
Adamska, A. [1 ]
Karczewska-Kupczewska, M. [1 ]
Lebkowska, A. [1 ]
Otziomek, E. [1 ]
Gorska, M. [1 ]
机构：
[1] Med Univ Bialystok, Dept Endocrinol Diabetol & Internal Med, Bialystok, Poland
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
223
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [21] Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21
    Sun, Yixuan
    Xia, Mingfeng
    Yan, Hongmei
    Han, Yamei
    Zhang, Feifei
    Hu, Zhimin
    Cui, Aoyuan
    Ma, Fengguang
    Liu, Zhengshuai
    Gong, Qi
    Chen, Xuqing
    Gao, Jing
    Bian, Hua
    Tan, Yi
    Li, Yu
    Gao, Xin
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (02) : 374 - 387
  • [22] Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin Sensitivity
    Berglund, Eric D.
    Li, Candice Y.
    Bina, Holly A.
    Lynes, Sara E.
    Michael, M. Dodson
    Shanafelt, Armen B.
    Kharitonenkov, Alexei
    Wasserman, David H.
    ENDOCRINOLOGY, 2009, 150 (09) : 4084 - 4093
  • [23] Naringenin Prevents Obesity, Hepatic Steatosis, and Glucose Intolerance in Male Mice Independent of Fibroblast Growth Factor 21
    Assini, Julia M.
    Mulvihill, Erin E.
    Burke, Amy C.
    Sutherland, Brian G.
    Telford, Dawn E.
    Chhoker, Sanjiv S.
    Sawyez, Cynthia G.
    Drangova, Maria
    Adams, Andrew C.
    Kharitonenkov, Alexei
    Pin, Christopher L.
    Huff, Murray W.
    ENDOCRINOLOGY, 2015, 156 (06) : 2087 - 2102
  • [24] RELATIONSHIP BETWEEN SERUM FIBROBLAST GROWTH FACTOR 21 LEVELS AND ARTERIOSCLEROSIS FACTORS IN CHRONIC HEMODIALYSIS PATIENTS
    Ogawa, Tetsuya
    Hosoda, Yumi
    Shimada, Miki
    Nishizawa, Yoko
    Shino, Midori
    Shimizu, Himiko
    Inoue, Tomoko
    Yamashita, Tetsuri
    Kyono, Ai
    Higuchi, Chieko
    Omae, Kiyotsugu
    Sakura, Hiroshi
    Nitta, Kosaku
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 652 - 652
  • [25] Increased Fibroblast Growth Factor 21 Serum Levels and Impaired Endothelial Function in Children With Obesity and Metabolic Disorder
    Domouzoglou, Eleni
    Vlahos, Antonios
    Challa, Anna
    Papafaklis, Michail
    Tsatsoulis, Agathocles
    Michalis, Lampros
    Chaliasos, Nikolaos
    Naka, Katerina
    EUROPEAN JOURNAL OF PEDIATRICS, 2019, 178 (11) : 1772 - 1772
  • [26] Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes
    Berti, Lucia
    Irmler, Martin
    Zdichavsky, Marty
    Meile, Tobias
    Boehm, Anja
    Stefan, Norbert
    Fritsche, Andreas
    Beckers, Johannes
    Koenigsrainer, Alfred
    Haering, Hans-Ulrich
    de Angelis, Martin Hrabe
    Staiger, Harald
    MOLECULAR METABOLISM, 2015, 4 (07): : 519 - 527
  • [27] STRONG CORRELATIONS BETWEEN SERUM FIBROBLAST GROWTH FACTOR 21 LEVEL AND LIPID PARAMETERS IN PATIENTS WITH AUTOIMMUNE THYROIDITIS
    Berta, E.
    Bodor, M.
    Halmi, S.
    Lengyel, I.
    Dioszegi, A.
    Katko, M.
    Seres, I.
    Nagy, E. V.
    Paragh, G.
    Harangi, M.
    ATHEROSCLEROSIS, 2021, 331 : E201 - E201
  • [28] Serum Fibroblast Growth Factor 21 Is Associated with Adverse Lipid Profiles and γ-Glutamyltransferase But Not Insulin Sensitivity in Chinese Subjects
    Li, Huating
    Bao, Yuqian
    Xu, Aimin
    Pan, Xiaoping
    Lu, Junxi
    Wu, Haiya
    Lu, Huijuan
    Xiang, Kunsan
    Jia, Weiping
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (06): : 2151 - 2156
  • [29] Serum Fibroblast Growth Factor 21 in Obese Children and Its Dynamic Changes during an Oral Glucose Challenge
    Korwutthikulrangsri, Manassawee
    Poomthavorn, Preamrudee
    Mahachoklertwattana, Pat
    Chanprasertyothin, Suwannee
    Khlairit, Patcharin
    Pongratanakul, Sarunyu
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [30] Association of serum fibroblast growth factor 21 and urinary glucose excretion in hospitalized patients with type 2 diabetes
    Zhang, Rui
    Cai, Xiaoling
    Du, Yongrui
    Liu, Liu
    Han, Xueyao
    Liu, Wei
    Gong, Siqian
    Zhou, Xianghai
    Wang, Xiangqing
    Wen, Xin
    Ji, Linong
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (01)
12345